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Background
• Reported adherence rates in CF are as low as 40-50%
• In our own adult patient (n = 410) adherence is 63% 
(medication possession ratio) White et al (2017)
• On-line adherence programmes for adults with CF have not 
yet been fully evaluated
• We aimed to determine the impact on adherence of a web-
based intervention for adults with CF 
White H, Shaw N, Denman S, Pollard K, Wynne S, Peckham DG. (2017) Variation in lung function as a 
Wmarker of adherence to oral and inhaled medication in cystic fibrosis European Respiratory Journal 
2017 Mar 8;49(3). 
Phase 1 (Module development)
• 6 on-line modules developed
• 40 video stories filmed and 
embedded within all  giving reasons 
to change and motivations to take 
treatment eg
– Parenthood
– Further study
– Availability for new treatments
Development
• Interactive material
• Integrated ‘drag and                  
drop’, games, quiz
– Nutrition
– Pancreatic enzyme 
replacement therapy
– Vitamins
– Airways & treatments
– Antibiotics
– Liver disease
2nd phase - RCT design
• Usual care or web-based intervention 
(n=100)
• Participants issued with tablet technology 
• Granted structured access over 12 
months
• Modules released at intervals
• Access tracked on-line
• Facility to gather participant feedback on 
the system
Results
• Data collected at baseline, 6 months and 1 year 
– Adherence (Medication possession ratio)*
– Knowledge questionnaire*
– QoL (CFQ-R)*
– Anthropometric data
– Respiratory function [FEV1(%), FVC(%), FEV1 rate of decline (% )and 
coefficient variation FEV1 (%)
– Fat soluble vitamin status
* Collected at baseline and 1 year only
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Conclusion
• A web based adherence intervention has shown
– Improved trends in Vitamin A,D, (but no significant changes 
in values at 6 months above controls) 
• Significant improvements for those with suboptimal Vitamin levels 
at baseline were shown
– No changes in lung function, variation in lung function or 
rate of lung decline above that of controls
– No changes in BMI above that of controls
– Full evaluation at 1 year is now required
